SlideShare a Scribd company logo
HEPATITIS
and
ALCOHOLIC LIVER DISEASE
Presented by
Dr. Arun Kumar
(M. Pharm., PDCTM, PhD)
Principal
Parmarth College of Pharmacy, Hapur
UNIT-IV (PATHOPHYSIOLOGY)
• The word is derived from the Greek words ‘hepar’
meaning "liver” and ‘itis’ meaning "inflammation".
• Hepatitis refers to an inflammatory condition of the
liver. It’s commonly caused by a viral infection, but
there are other possible causes of hepatitis.
• These include autoimmune hepatitis and hepatitis
that occurs as a secondary result of medications,
drugs, toxins, and alcohol.
• Autoimmune hepatitis is a disease that occurs when
the body makes antibodies against the liver tissue.
HEPATITIS
• Some people have no symptoms whereas others
develop yellow discoloration of the skin and
whites of the eyes, poor
appetite, vomiting, tiredness, abdominal pain,
or diarrhea.
• Hepatitis may be temporary (acute) or long
term (chronic) depending on whether it lasts for
less than or more than six months.
• Acute hepatitis can sometimes resolve on its own,
progress to chronic hepatitis, or rarely result
in acute liver failure.
• Over time the chronic form may progress
to scarring (hard tissue) of the liver, liver failure,
or liver cancer.
Causes:
• Causes of hepatitis can be divided into the
following major categories: infectious, metabolic,
ischemic, autoimmune, genetic, and other.
• Infectious agents include viruses, bacteria, and
parasites.
• Toxins, drugs, alcohol, and non-alcoholic fatty liver
disease are metabolic causes of liver injury and
inflammation.
• Autoimmune and genetic causes of hepatitis
involve genetic predispositions and tend to affect
characteristic populations.
• The most common cause worldwide is viruses.
Signs and symptoms:
• Acute hepatitis
• The initial prodromal phase (preceding symptoms)
involves non-specific and flu-like symptoms common
to many acute viral infections.
• These include fatigue, nausea, vomiting, poor
appetite, joint pain, and headaches.
• Fever, when present, is most common in cases of
hepatitis A and E. Late in this phase, people can
experience liver-specific symptoms,
including choluria (dark urine) and clay-colored
stools.
• Yellowing of the skin and whites of the eyes follow
the prodrome after about 1–2 weeks and can last for
up to 4 weeks.
• The non-specific symptoms seen in the
prodromal typically resolve by this time, but
people will develop an enlarged liver and right
upper abdominal pain or discomfort.
• 10–20% of people will also experience
an enlarged spleen, while some people will also
experience a mild unintentional weight loss.
• Cases of drug-induced hepatitis can manifest
with systemic signs of an allergic reaction
including rash, fever, serositis (inflammation of
membranes lining certain organs), elevated
eosinophils (a type of white blood cell),
and suppression of bone marrow activity.
Hepatitis A
• Hepatitis A is caused by eating food and drinking
water contaminated with a virus called HAV. It
can also be caused by contact during sex.
• While it can cause swelling and inflammation in
the liver, it doesn't lead to chronic, or life long,
disease.
• Almost everyone who gets hepatitis A has a full
recovery. There is a vaccine for hepatitis A that
can be given to children or at-risk adults.
• Practicing good hygiene and hand washing can
also reduce your risk of contracting hepatitis A
virus.
Hepatitis B
• Hepatitis B is caused by the virus HBV. It is spread by
contact with an infected person's blood, semen, or
other body fluid. And, it is a sexually transmitted
disease (STD). You can get hepatitis B by:
• Having unprotected sex with an infected person.
• Sharing drug needles (for illegal drugs like heroin and
cocaine or legal drugs like vitamins and steroids).
• Getting pricked with a needle that has infected blood
on it (health care workers can get hepatitis B this
way).
• With hepatitis B, the liver also swells. Hepatitis B can
be a serious infection that can cause liver damage,
which may result in cancer.
Hepatitis C
• Hepatitis C is caused by the virus HCV. It is spread
the same way as hepatitis B, through contact with an
infected person's blood, semen, or body fluid.
• Like hepatitis B, hepatitis C causes swelling of the
liver and can cause liver damage that can lead to
cancer.
• Most people who have hepatitis C develop a chronic
infection. This may lead to a scarring of the liver,
called cirrhosis.
• Blood banks test all donated blood for hepatitis C,
greatly reducing the risk of getting the virus from
blood transfusions or blood products.
Hepatitis D
• Hepatitis D is caused by the virus HDV. You can only
get hepatitis D if you are already infected with
hepatitis B. It is spread through contact with
infected blood, dirty needles that have HDV on
them, and unprotected sex with a person infected
with HDV.
• Hepatitis D causes swelling of the liver.
Hepatitis E
• Hepatitis E is caused by the virus HEV. You get
hepatitis E by drinking water infected with the virus.
It causes swelling of the liver, but no long-term
damage. It can also be spread through sexual
contact.
Pathophysiology:
• The specific mechanism varies and depends on the
underlying cause of the hepatitis. Generally, there is
an initial insult that causes liver injury and activation
of an inflammatory response, which can become
chronic, leading to progressive fibrosis and cirrhosis.
• The pathway by which hepatic viruses cause viral
hepatitis is best understood in the case of hepatitis B
and C.
• The viruses do not directly cause apoptosis (cell
death). Rather, infection of liver cells activates
the innate and adaptive arms of the immune
system leading to an inflammatory response which
causes cellular damage and death.
Prevention and Treatment:
• Vaccination
• Treatment of hepatitis varies based on the form (acute
versus chronic), severity of disease, and cause.
• Hepatitis A generally does not progress to a chronic state
and rarely requires hospitalization. Treatment is
supportive and includes such measures as providing
intravenous (IV) hydration and maintaining adequate
nutrition.
• Hepatitis B more severe acute cases, patients have been
successfully treated with antiviral therapy similar to that
used in cases of chronic hepatitis B, with nucleoside
analogues such as lamivudine, entecavir or tenofovir.
Injectable interferon alpha was the first therapy approved
for chronic hepatitis B.
• Hepatitis C In contrast to hepatitis A and B,
progression to chronic hepatitis C is much more
common.
• The ultimate goal of hepatitis C treatment is
prevention of hepatocellular carcinoma (HCC).
• The best way to reduce the long-term risk of HCC is
to achieve sustained virological response (SVR).
• SVR is defined as an undetectable viral load at 12
weeks after treatment completion and indicates a
cure.
• Currently available treatments include indirect and
direct acting antiviral drugs.
• The indirect acting antivirals include pegylated
interferon (PEG IFN) and ribavirin (RBV), which in
combination have historically been the basis of
therapy for HCV.
• Hepatitis D is difficult to treat, and effective
treatments are lacking. Interferon alpha has
proven effective at inhibiting viral activity but
only on a temporary basis.
• Hepatitis E Similar to hepatitis A, treatment of
hepatitis E is supportive and includes rest and
ensuring adequate nutrition and hydration.
Hospitalization may be required for particularly
severe cases or for pregnant women.
• Alcoholic liver disease is a term that
encompasses the liver manifestations
of alcohol over consumption, including fatty liver,
alcoholic hepatitis, and chronic hepatitis with
liver fibrosis or cirrhosis.
• It is the major cause of liver disease.
Although steatosis (fatty liver) will develop in any
individual who consumes a large quantity of
alcoholic beverages over a long period of time,
this process is transient and reversible. Of all
chronic heavy drinkers, only 15–20% develops
hepatitis or cirrhosis, which can occur
concomitantly or in succession.
Early symptoms:
• Abdominal (tummy) pain
• Loss of appetite
• Fatigue
• Diarrhea
• Yellowing of the skin and whites of the eyes
(jaundice)
• Swelling in the legs, ankles and feet, due to a build-
up of fluid (oedema)
• Swelling in abdomen, due to a build-up of fluid
known as ascites
• A high temperature (fever) and shivering attacks
• Very itchy skin
• Hair loss
• Unusually curved fingertips and nails (clubbed
fingers)
• Blotchy red palms
• Significant weight loss
• Weakness and muscle wasting
• Confusion and memory problems, trouble sleeping
(insomnia) and changes in your personality due to a
build-up of toxins in the brain
• Vomiting blood and black, tarry stools due
to internal bleeding
• A tendency to bleed and bruise more easily, such as
frequent nosebleeds and bleeding gums
• Increased sensitivity to alcohol and drugs (because
the liver can't process them)
Pathophysiology:
• Fatty change
• Alcoholism causes development of large fatty
globules (macro vesicular steatosis) throughout
the liver and can begin to occur after a few days
of heavy drinking.
• Alcohol is metabolized by alcohol
dehydrogenase (ADH) into acetaldehyde, then
further metabolized by aldehyde
dehydrogenase (ALDH) into acetic acid, which is
finally oxidized into carbon dioxide (CO2) and
water ( H2O).
• This process generates NADH, and increases the
NADH/NAD+ ratio.
• A higher NADH concentration induces fatty acid
synthesis while a decreased NAD level results in
decreased fatty acid oxidation.
• Subsequently, the higher levels of fatty acids
signal the liver cells to compound it to glycerol to
form triglycerides.
• These triglycerides accumulate, resulting in fatty
liver.
• Alcoholic hepatitis
• Alcoholic hepatitis is characterized by the
inflammation of hepatocytes.
• Between 10% and 35% of heavy drinkers develop
alcoholic hepatitis.
• While development of hepatitis is not directly
related to the dose of alcohol, some people seem
more prone to this reaction than others.
• This is called alcoholic steato necrosis and the
inflammation appears to predispose to
liver fibrosis.
• Cirrhosis
• Cirrhosis is a late stage of serious liver disease
marked by inflammation (swelling), fibrosis (cellular
hardening) and damaged membranes preventing
detoxification of chemicals in the body, ending in
scarring and necrosis (cell death).
• Between 10% to 20% of heavy drinkers will develop
cirrhosis of the liver. Acetaldehyde may be
responsible for alcohol-induced fibrosis by
stimulating collagen deposition by hepatic stellate
cells.
• The production of oxidants derived from NADPH
oxidase and/or cytochrome P-450 2E1 and the
formation of acetaldehyde-protein adducts damage
the cell membrane.
Prevention:
• Maintaining normal weight.
• Control obesity.
• Healthy diet.
• Avoid alcohol abuse.
• Avoid hepatotoxic drugs.
• Safe sex.
Treatment:
• Drugs: Sylimarin and sometimes corticosteroids.
THANK YOU

More Related Content

What's hot

Anemia basic and approach
Anemia basic and approachAnemia basic and approach
Anemia basic and approach
Haseeb Ahmed Bhatti
 
Alcoholic liver disease mbbs
Alcoholic liver disease mbbsAlcoholic liver disease mbbs
Alcoholic liver disease mbbs
santusan
 
Alcoholic liver disease
Alcoholic liver diseaseAlcoholic liver disease
Alcoholic liver disease
Mark Hall
 
Investigating a case of alcoholic liver disease
Investigating a case of alcoholic liver diseaseInvestigating a case of alcoholic liver disease
Investigating a case of alcoholic liver disease
All India Institute of Medical Sciences, Mangalagiri
 
Alcoholic Liver Disease- Aditya Pandey
Alcoholic Liver Disease- Aditya PandeyAlcoholic Liver Disease- Aditya Pandey
Alcoholic Liver Disease- Aditya Pandey
Aditya Pandey
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
SUNIL KUMAR PEDDANA
 
Liver cirrhosis
Liver cirrhosisLiver cirrhosis
Liver cirrhosis
mohit rulaniya
 
L24 alcoholic liver disease
L24 alcoholic liver diseaseL24 alcoholic liver disease
L24 alcoholic liver diseaseMohammad Manzoor
 
Approach to anemia
Approach to anemiaApproach to anemia
Approach to anemia
Melaku Yetbarek,MD
 
Alcoholic liver cirrhosis
Alcoholic liver cirrhosisAlcoholic liver cirrhosis
Alcoholic liver cirrhosissurya720
 
L25,26 metabolic & inherited liver disease
L25,26 metabolic & inherited liver diseaseL25,26 metabolic & inherited liver disease
L25,26 metabolic & inherited liver diseaseMohammad Manzoor
 
Cirrhosis of Liver
Cirrhosis of LiverCirrhosis of Liver
Cirrhosis of Liver
Abhay Rajpoot
 
Alcoholic Liver Disease PPT.
Alcoholic Liver Disease PPT.Alcoholic Liver Disease PPT.
Alcoholic Liver Disease PPT.JDLona
 
Alcoholic Liver Disease
Alcoholic Liver DiseaseAlcoholic Liver Disease
Alcoholic Liver Disease
Flemin Thomas
 
Anemia in critical illness
Anemia in critical illnessAnemia in critical illness
Anemia in critical illnesssesegreti1
 
alcoholoc liver disease
alcoholoc liver diseasealcoholoc liver disease
alcoholoc liver disease
Dr B Naga Raju
 
liver cirrhosis
liver cirrhosis liver cirrhosis
Anemia. PPT
Anemia. PPTAnemia. PPT
Anemia. PPT
ROMAN BAJRANG
 
ALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASEALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASE
Mansi Shah
 

What's hot (20)

Anemia basic and approach
Anemia basic and approachAnemia basic and approach
Anemia basic and approach
 
Alcoholic liver disease mbbs
Alcoholic liver disease mbbsAlcoholic liver disease mbbs
Alcoholic liver disease mbbs
 
Alcoholic liver disease
Alcoholic liver diseaseAlcoholic liver disease
Alcoholic liver disease
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Investigating a case of alcoholic liver disease
Investigating a case of alcoholic liver diseaseInvestigating a case of alcoholic liver disease
Investigating a case of alcoholic liver disease
 
Alcoholic Liver Disease- Aditya Pandey
Alcoholic Liver Disease- Aditya PandeyAlcoholic Liver Disease- Aditya Pandey
Alcoholic Liver Disease- Aditya Pandey
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
 
Liver cirrhosis
Liver cirrhosisLiver cirrhosis
Liver cirrhosis
 
L24 alcoholic liver disease
L24 alcoholic liver diseaseL24 alcoholic liver disease
L24 alcoholic liver disease
 
Approach to anemia
Approach to anemiaApproach to anemia
Approach to anemia
 
Alcoholic liver cirrhosis
Alcoholic liver cirrhosisAlcoholic liver cirrhosis
Alcoholic liver cirrhosis
 
L25,26 metabolic & inherited liver disease
L25,26 metabolic & inherited liver diseaseL25,26 metabolic & inherited liver disease
L25,26 metabolic & inherited liver disease
 
Cirrhosis of Liver
Cirrhosis of LiverCirrhosis of Liver
Cirrhosis of Liver
 
Alcoholic Liver Disease PPT.
Alcoholic Liver Disease PPT.Alcoholic Liver Disease PPT.
Alcoholic Liver Disease PPT.
 
Alcoholic Liver Disease
Alcoholic Liver DiseaseAlcoholic Liver Disease
Alcoholic Liver Disease
 
Anemia in critical illness
Anemia in critical illnessAnemia in critical illness
Anemia in critical illness
 
alcoholoc liver disease
alcoholoc liver diseasealcoholoc liver disease
alcoholoc liver disease
 
liver cirrhosis
liver cirrhosis liver cirrhosis
liver cirrhosis
 
Anemia. PPT
Anemia. PPTAnemia. PPT
Anemia. PPT
 
ALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASEALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASE
 

Similar to Hepatitis, alcohol liver disease

HEPATITIS.pptx
HEPATITIS.pptxHEPATITIS.pptx
HEPATITIS.pptx
anjalisaini751329
 
DISEASES OF LIVER
DISEASES OF LIVERDISEASES OF LIVER
DISEASES OF LIVER
VIVEK MANI YADAV
 
HEPATITIS- L C 2017.pptx
HEPATITIS- L C 2017.pptxHEPATITIS- L C 2017.pptx
HEPATITIS- L C 2017.pptx
SharonKabwela
 
Hepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptxHepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptx
Sudipta Roy
 
Hepatitis _null-32_111838_010528.ppt
Hepatitis _null-32_111838_010528.pptHepatitis _null-32_111838_010528.ppt
Hepatitis _null-32_111838_010528.ppt
AugustusCaesar7
 
hepatitis
hepatitishepatitis
hepatitis
Hari kesavan
 
Viral hepatitis Mr Mulundano
Viral hepatitis Mr MulundanoViral hepatitis Mr Mulundano
Viral hepatitis Mr Mulundano
Maybin Mulundano
 
world hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptxworld hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptx
Khushi292056
 
Presentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdfPresentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdf
ElahehMohammadi4
 
Presentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdfPresentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdf
ElahehMohammadi4
 
liver mediated diseases and viral hepatitis
liver mediated diseases and viral hepatitisliver mediated diseases and viral hepatitis
liver mediated diseases and viral hepatitisRa Bia
 
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
druroojarshad9454
 
Hepatitis ppt
Hepatitis pptHepatitis ppt
Hepatitis ppt
KalpanaKawan1
 
Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...
Shankar Hemam
 
Viral hepatitis in human
Viral hepatitis in humanViral hepatitis in human
Viral hepatitis in human
Shane Prasad
 
Report h.c. lec print green
Report h.c. lec print greenReport h.c. lec print green
Report h.c. lec print greenCharmaine Granil
 
Report h.c. lec print green
Report h.c. lec print greenReport h.c. lec print green
Report h.c. lec print greenCharmaine Granil
 
Report h.c. lec 2
Report h.c. lec 2Report h.c. lec 2
Report h.c. lec 2
Charmaine Granil
 
Hepatitis A
Hepatitis AHepatitis A
Hepatitis A
PalashGhosal1
 

Similar to Hepatitis, alcohol liver disease (20)

HEPATITIS.pptx
HEPATITIS.pptxHEPATITIS.pptx
HEPATITIS.pptx
 
DISEASES OF LIVER
DISEASES OF LIVERDISEASES OF LIVER
DISEASES OF LIVER
 
HEPATITIS- L C 2017.pptx
HEPATITIS- L C 2017.pptxHEPATITIS- L C 2017.pptx
HEPATITIS- L C 2017.pptx
 
Hepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptxHepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptx
 
Hepatitis _null-32_111838_010528.ppt
Hepatitis _null-32_111838_010528.pptHepatitis _null-32_111838_010528.ppt
Hepatitis _null-32_111838_010528.ppt
 
hepatitis
hepatitishepatitis
hepatitis
 
Viral hepatitis Mr Mulundano
Viral hepatitis Mr MulundanoViral hepatitis Mr Mulundano
Viral hepatitis Mr Mulundano
 
world hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptxworld hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptx
 
Presentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdfPresentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdf
 
Presentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdfPresentation on cirrhosis by elaheh.pdf
Presentation on cirrhosis by elaheh.pdf
 
Infective hepatitis and cirrhosis
Infective hepatitis and cirrhosisInfective hepatitis and cirrhosis
Infective hepatitis and cirrhosis
 
liver mediated diseases and viral hepatitis
liver mediated diseases and viral hepatitisliver mediated diseases and viral hepatitis
liver mediated diseases and viral hepatitis
 
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
 
Hepatitis ppt
Hepatitis pptHepatitis ppt
Hepatitis ppt
 
Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...
 
Viral hepatitis in human
Viral hepatitis in humanViral hepatitis in human
Viral hepatitis in human
 
Report h.c. lec print green
Report h.c. lec print greenReport h.c. lec print green
Report h.c. lec print green
 
Report h.c. lec print green
Report h.c. lec print greenReport h.c. lec print green
Report h.c. lec print green
 
Report h.c. lec 2
Report h.c. lec 2Report h.c. lec 2
Report h.c. lec 2
 
Hepatitis A
Hepatitis AHepatitis A
Hepatitis A
 

More from Arun Kumar

Rain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun KumarRain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun Kumar
Arun Kumar
 
Cancer
CancerCancer
Cancer
Arun Kumar
 
PATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINEPATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINE
Arun Kumar
 
Thyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMARThyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMAR
Arun Kumar
 
Epilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun KumarEpilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun Kumar
Arun Kumar
 
Asthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun KumarAsthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun Kumar
Arun Kumar
 
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMARHYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
Arun Kumar
 
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY EnzymeD. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
Arun Kumar
 

More from Arun Kumar (8)

Rain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun KumarRain water harvesting by Dr. Arun Kumar
Rain water harvesting by Dr. Arun Kumar
 
Cancer
CancerCancer
Cancer
 
PATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINEPATHOLOGY OF BLOOD AND URINE
PATHOLOGY OF BLOOD AND URINE
 
Thyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMARThyroid diseases BY DR ARUN KUMAR
Thyroid diseases BY DR ARUN KUMAR
 
Epilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun KumarEpilepsy Presented by Dr. Arun Kumar
Epilepsy Presented by Dr. Arun Kumar
 
Asthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun KumarAsthma Presentation by Dr. Arun Kumar
Asthma Presentation by Dr. Arun Kumar
 
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMARHYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
HYPERTENSION TOPIC PREPARED BY DR. ARUN KUMAR
 
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY EnzymeD. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
D. Pharm BIOCHEMISTRY AND CLINICAL PATHOLOGY Enzyme
 

Recently uploaded

Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 

Recently uploaded (20)

Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 

Hepatitis, alcohol liver disease

  • 1. HEPATITIS and ALCOHOLIC LIVER DISEASE Presented by Dr. Arun Kumar (M. Pharm., PDCTM, PhD) Principal Parmarth College of Pharmacy, Hapur UNIT-IV (PATHOPHYSIOLOGY)
  • 2. • The word is derived from the Greek words ‘hepar’ meaning "liver” and ‘itis’ meaning "inflammation". • Hepatitis refers to an inflammatory condition of the liver. It’s commonly caused by a viral infection, but there are other possible causes of hepatitis. • These include autoimmune hepatitis and hepatitis that occurs as a secondary result of medications, drugs, toxins, and alcohol. • Autoimmune hepatitis is a disease that occurs when the body makes antibodies against the liver tissue. HEPATITIS
  • 3. • Some people have no symptoms whereas others develop yellow discoloration of the skin and whites of the eyes, poor appetite, vomiting, tiredness, abdominal pain, or diarrhea. • Hepatitis may be temporary (acute) or long term (chronic) depending on whether it lasts for less than or more than six months. • Acute hepatitis can sometimes resolve on its own, progress to chronic hepatitis, or rarely result in acute liver failure. • Over time the chronic form may progress to scarring (hard tissue) of the liver, liver failure, or liver cancer.
  • 4. Causes: • Causes of hepatitis can be divided into the following major categories: infectious, metabolic, ischemic, autoimmune, genetic, and other. • Infectious agents include viruses, bacteria, and parasites. • Toxins, drugs, alcohol, and non-alcoholic fatty liver disease are metabolic causes of liver injury and inflammation. • Autoimmune and genetic causes of hepatitis involve genetic predispositions and tend to affect characteristic populations. • The most common cause worldwide is viruses.
  • 5. Signs and symptoms: • Acute hepatitis • The initial prodromal phase (preceding symptoms) involves non-specific and flu-like symptoms common to many acute viral infections. • These include fatigue, nausea, vomiting, poor appetite, joint pain, and headaches. • Fever, when present, is most common in cases of hepatitis A and E. Late in this phase, people can experience liver-specific symptoms, including choluria (dark urine) and clay-colored stools. • Yellowing of the skin and whites of the eyes follow the prodrome after about 1–2 weeks and can last for up to 4 weeks.
  • 6. • The non-specific symptoms seen in the prodromal typically resolve by this time, but people will develop an enlarged liver and right upper abdominal pain or discomfort. • 10–20% of people will also experience an enlarged spleen, while some people will also experience a mild unintentional weight loss. • Cases of drug-induced hepatitis can manifest with systemic signs of an allergic reaction including rash, fever, serositis (inflammation of membranes lining certain organs), elevated eosinophils (a type of white blood cell), and suppression of bone marrow activity.
  • 7.
  • 8. Hepatitis A • Hepatitis A is caused by eating food and drinking water contaminated with a virus called HAV. It can also be caused by contact during sex. • While it can cause swelling and inflammation in the liver, it doesn't lead to chronic, or life long, disease. • Almost everyone who gets hepatitis A has a full recovery. There is a vaccine for hepatitis A that can be given to children or at-risk adults. • Practicing good hygiene and hand washing can also reduce your risk of contracting hepatitis A virus.
  • 9. Hepatitis B • Hepatitis B is caused by the virus HBV. It is spread by contact with an infected person's blood, semen, or other body fluid. And, it is a sexually transmitted disease (STD). You can get hepatitis B by: • Having unprotected sex with an infected person. • Sharing drug needles (for illegal drugs like heroin and cocaine or legal drugs like vitamins and steroids). • Getting pricked with a needle that has infected blood on it (health care workers can get hepatitis B this way). • With hepatitis B, the liver also swells. Hepatitis B can be a serious infection that can cause liver damage, which may result in cancer.
  • 10. Hepatitis C • Hepatitis C is caused by the virus HCV. It is spread the same way as hepatitis B, through contact with an infected person's blood, semen, or body fluid. • Like hepatitis B, hepatitis C causes swelling of the liver and can cause liver damage that can lead to cancer. • Most people who have hepatitis C develop a chronic infection. This may lead to a scarring of the liver, called cirrhosis. • Blood banks test all donated blood for hepatitis C, greatly reducing the risk of getting the virus from blood transfusions or blood products.
  • 11. Hepatitis D • Hepatitis D is caused by the virus HDV. You can only get hepatitis D if you are already infected with hepatitis B. It is spread through contact with infected blood, dirty needles that have HDV on them, and unprotected sex with a person infected with HDV. • Hepatitis D causes swelling of the liver. Hepatitis E • Hepatitis E is caused by the virus HEV. You get hepatitis E by drinking water infected with the virus. It causes swelling of the liver, but no long-term damage. It can also be spread through sexual contact.
  • 12. Pathophysiology: • The specific mechanism varies and depends on the underlying cause of the hepatitis. Generally, there is an initial insult that causes liver injury and activation of an inflammatory response, which can become chronic, leading to progressive fibrosis and cirrhosis. • The pathway by which hepatic viruses cause viral hepatitis is best understood in the case of hepatitis B and C. • The viruses do not directly cause apoptosis (cell death). Rather, infection of liver cells activates the innate and adaptive arms of the immune system leading to an inflammatory response which causes cellular damage and death.
  • 13. Prevention and Treatment: • Vaccination • Treatment of hepatitis varies based on the form (acute versus chronic), severity of disease, and cause. • Hepatitis A generally does not progress to a chronic state and rarely requires hospitalization. Treatment is supportive and includes such measures as providing intravenous (IV) hydration and maintaining adequate nutrition. • Hepatitis B more severe acute cases, patients have been successfully treated with antiviral therapy similar to that used in cases of chronic hepatitis B, with nucleoside analogues such as lamivudine, entecavir or tenofovir. Injectable interferon alpha was the first therapy approved for chronic hepatitis B.
  • 14. • Hepatitis C In contrast to hepatitis A and B, progression to chronic hepatitis C is much more common. • The ultimate goal of hepatitis C treatment is prevention of hepatocellular carcinoma (HCC). • The best way to reduce the long-term risk of HCC is to achieve sustained virological response (SVR). • SVR is defined as an undetectable viral load at 12 weeks after treatment completion and indicates a cure. • Currently available treatments include indirect and direct acting antiviral drugs. • The indirect acting antivirals include pegylated interferon (PEG IFN) and ribavirin (RBV), which in combination have historically been the basis of therapy for HCV.
  • 15. • Hepatitis D is difficult to treat, and effective treatments are lacking. Interferon alpha has proven effective at inhibiting viral activity but only on a temporary basis. • Hepatitis E Similar to hepatitis A, treatment of hepatitis E is supportive and includes rest and ensuring adequate nutrition and hydration. Hospitalization may be required for particularly severe cases or for pregnant women.
  • 16.
  • 17. • Alcoholic liver disease is a term that encompasses the liver manifestations of alcohol over consumption, including fatty liver, alcoholic hepatitis, and chronic hepatitis with liver fibrosis or cirrhosis. • It is the major cause of liver disease. Although steatosis (fatty liver) will develop in any individual who consumes a large quantity of alcoholic beverages over a long period of time, this process is transient and reversible. Of all chronic heavy drinkers, only 15–20% develops hepatitis or cirrhosis, which can occur concomitantly or in succession.
  • 18. Early symptoms: • Abdominal (tummy) pain • Loss of appetite • Fatigue • Diarrhea • Yellowing of the skin and whites of the eyes (jaundice) • Swelling in the legs, ankles and feet, due to a build- up of fluid (oedema) • Swelling in abdomen, due to a build-up of fluid known as ascites • A high temperature (fever) and shivering attacks • Very itchy skin • Hair loss
  • 19. • Unusually curved fingertips and nails (clubbed fingers) • Blotchy red palms • Significant weight loss • Weakness and muscle wasting • Confusion and memory problems, trouble sleeping (insomnia) and changes in your personality due to a build-up of toxins in the brain • Vomiting blood and black, tarry stools due to internal bleeding • A tendency to bleed and bruise more easily, such as frequent nosebleeds and bleeding gums • Increased sensitivity to alcohol and drugs (because the liver can't process them)
  • 20.
  • 21. Pathophysiology: • Fatty change • Alcoholism causes development of large fatty globules (macro vesicular steatosis) throughout the liver and can begin to occur after a few days of heavy drinking. • Alcohol is metabolized by alcohol dehydrogenase (ADH) into acetaldehyde, then further metabolized by aldehyde dehydrogenase (ALDH) into acetic acid, which is finally oxidized into carbon dioxide (CO2) and water ( H2O).
  • 22. • This process generates NADH, and increases the NADH/NAD+ ratio. • A higher NADH concentration induces fatty acid synthesis while a decreased NAD level results in decreased fatty acid oxidation. • Subsequently, the higher levels of fatty acids signal the liver cells to compound it to glycerol to form triglycerides. • These triglycerides accumulate, resulting in fatty liver.
  • 23. • Alcoholic hepatitis • Alcoholic hepatitis is characterized by the inflammation of hepatocytes. • Between 10% and 35% of heavy drinkers develop alcoholic hepatitis. • While development of hepatitis is not directly related to the dose of alcohol, some people seem more prone to this reaction than others. • This is called alcoholic steato necrosis and the inflammation appears to predispose to liver fibrosis.
  • 24. • Cirrhosis • Cirrhosis is a late stage of serious liver disease marked by inflammation (swelling), fibrosis (cellular hardening) and damaged membranes preventing detoxification of chemicals in the body, ending in scarring and necrosis (cell death). • Between 10% to 20% of heavy drinkers will develop cirrhosis of the liver. Acetaldehyde may be responsible for alcohol-induced fibrosis by stimulating collagen deposition by hepatic stellate cells. • The production of oxidants derived from NADPH oxidase and/or cytochrome P-450 2E1 and the formation of acetaldehyde-protein adducts damage the cell membrane.
  • 25. Prevention: • Maintaining normal weight. • Control obesity. • Healthy diet. • Avoid alcohol abuse. • Avoid hepatotoxic drugs. • Safe sex. Treatment: • Drugs: Sylimarin and sometimes corticosteroids.